These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 2336751

  • 1. [Plasma lipids in patients with chronic glomerulonephritis].
    Kolmakova EV.
    Urol Nefrol (Mosk); 1990; (1):16-9. PubMed ID: 2336751
    [Abstract] [Full Text] [Related]

  • 2. [Characteristics of lipoprotein metabolism impairments in nephrotic syndrome].
    Titov VN, Tvorogova MG, Levitova EN, Krylova EA.
    Vopr Med Khim; 1983; 29(2):17-23. PubMed ID: 6858031
    [Abstract] [Full Text] [Related]

  • 3. [Lipiduria in the nephrotic syndrome].
    Neverov NI, Nikitina EA.
    Ter Arkh; 1992; 64(6):16-8. PubMed ID: 1440328
    [Abstract] [Full Text] [Related]

  • 4. Biochemical vitamin B6 deficiency in adults with chronic glomerulonephritides with and without the nephrotic syndrome.
    Labadarios D, Shephard GS, Mineur LG, Van Buuren AJ, Hutchison ME, Oosthuizen OJ.
    Int J Vitam Nutr Res; 1984; 54(4):313-9. PubMed ID: 6526596
    [Abstract] [Full Text] [Related]

  • 5. [Lipidemia in the nephrotic syndrome and the atherogenicity of the plasma].
    Kolmakova EV, Shulutko BI, Shishkin AN.
    Lik Sprava; 1992 Jun; (6):91-4. PubMed ID: 1455841
    [Abstract] [Full Text] [Related]

  • 6. [The lipid profile in children with nephrosis].
    Mena-Castro E, López-Rivera M, Pérez-Alcántara H, Ramírez-Zapata E, de Luna E.
    Bol Med Hosp Infant Mex; 1991 Jun; 48(6):420-5. PubMed ID: 1910557
    [Abstract] [Full Text] [Related]

  • 7. Incidence of nephrotic syndrome in patients with glomerulonephritis.
    Sonkodi S, Tichy B, Mágori A, Ormos J.
    Acta Med Hung; 1986 Jun; 43(3):311-3. PubMed ID: 3588169
    [Abstract] [Full Text] [Related]

  • 8. [Nephrotic syndrome in minimal change disease (kidney), focal segmental glomerulosclerosis, and focal mesangioproliferative glomerulonephritis].
    Voznesenskaia TS, Sergeeva TV.
    Ter Arkh; 2002 Jun; 74(6):31-3. PubMed ID: 12136479
    [Abstract] [Full Text] [Related]

  • 9. Comparison of lipid and fatty acid metabolism between minimal change nephrotic syndrome and membranous nephropathy.
    Fujita T, Nakamura N, Kumasaka R, Shimada M, Murakami R, Osawa H, Yamabe H, Okumura K.
    In Vivo; 2006 Jun; 20(6B):891-3. PubMed ID: 17203785
    [Abstract] [Full Text] [Related]

  • 10. [The role of immediate-type allergic reactions in the pathogenesis of the nephrotic syndrome].
    Shishkin AN.
    Ter Arkh; 1996 Jun; 68(6):19-21. PubMed ID: 8771676
    [Abstract] [Full Text] [Related]

  • 11. The predominance of membranoproliferative glomerulonephritis in childhood nephrotic syndrome in Ibadan, Nigeria.
    Asinobi AO, Gbadegesin RA, Adeyemo AA, Akang EE, Arowolo FA, Abiola OA, Osinusi K.
    West Afr J Med; 1999 Jun; 18(3):203-6. PubMed ID: 10593158
    [Abstract] [Full Text] [Related]

  • 12. [Changes in the serum lipid spectrum of glomerulonephritis patients].
    Nikulina GG, Petrun' NM, Pyrig LA, Mel'man NIa.
    Vrach Delo; 1985 Oct; (10):20-4. PubMed ID: 4090424
    [No Abstract] [Full Text] [Related]

  • 13. Lipoprotein profiles in a heterogeneous group of patients with nephrotic syndrome.
    Michaeli J, Bar-On H, Shafrir E.
    Isr J Med Sci; 1981 Nov; 17(11):1001-8. PubMed ID: 7319786
    [Abstract] [Full Text] [Related]

  • 14. Pathogenesis of lipid abnormalities in patients with nephrotic syndrome/proteinuria: clinical implications.
    Warwick GL, Packard CJ.
    Miner Electrolyte Metab; 1993 Nov; 19(3):115-26. PubMed ID: 8232098
    [Abstract] [Full Text] [Related]

  • 15. [Relationship between renal biopsy histopathology and profile of changes in serum protein, lipids and proteinuria in patients with nephrotic syndrome due to chronic glomerulonephritis].
    Wiecek A, Kokot F, Strzelczyk P, Witkowicz J, Karkoszka H, Chudek J, Irzyniec T, Klimek D.
    Pol Arch Med Wewn; 1993 Dec; 90(6):426-32. PubMed ID: 8146046
    [Abstract] [Full Text] [Related]

  • 16. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
    Tomura S, Ida T, Kuriyama R, Chida Y, Takeuchi J, Motomiya T, Yamazaki H.
    Clin Nephrol; 1982 Jan; 17(1):24-30. PubMed ID: 6459902
    [Abstract] [Full Text] [Related]

  • 17. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
    Lizakowski S, Zdrojewski Z, Jagodzinski P, Rutkowski B.
    Scand J Urol Nephrol; 2007 Jan; 41(3):237-42. PubMed ID: 17469034
    [Abstract] [Full Text] [Related]

  • 18. [Clinical assessment of lipid free-radical oxidation in chronic glomerulonephritis patients].
    Nazar PS, Galitskiĭ IaD, Martyniuk ES.
    Ter Arkh; 1987 Jan; 59(9):104-6. PubMed ID: 3424171
    [Abstract] [Full Text] [Related]

  • 19. Intraglomerular fibrin, platelet aggregation, and subendothelial deposits in lipoid nephrosis.
    Duffy JL, Cinque T, Grishman E, Churg J.
    J Clin Invest; 1970 Feb; 49(2):251-8. PubMed ID: 4189232
    [Abstract] [Full Text] [Related]

  • 20. [Serum lipids and lipoproteins in patients with hypertension and chronic glomerulonephritis].
    Kovsh OIa, Pirogova TF, Dundure BL, Guberman SL, Shafro IS.
    Vrach Delo; 1985 Feb; (2):61-5. PubMed ID: 3992989
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.